ticlopidine has been researched along with Glial Cell Tumors in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shchors, K | 1 |
| Massaras, A | 1 |
| Hanahan, D | 1 |
| Shipman, L | 1 |
2 other studies available for ticlopidine and Glial Cell Tumors
| Article | Year |
|---|---|
Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas with Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic Benefit.
Topics: Animals; Anticoagulants; Antidepressive Agents, Tricyclic; Antineoplastic Combined Chemotherapy Prot | 2015 |
Glioma: Repurposed drugs combined to amplify autophagy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Glioma; Imipramine; Ticlop | 2015 |